**Core Concept**
The patient's prolonged bleeding time is likely due to a drug-induced impairment of platelet function, which affects primary hemostasis. This can occur through various mechanisms, including inhibition of cyclooxygenase (COX) enzymes, which are crucial for the production of thromboxane A2 (TXA2), a potent platelet activator and aggregator.

**Why the Correct Answer is Right**
The correct answer is a drug that does not affect platelet function or primary hemostasis. Among the options provided, one drug does not interfere with platelet aggregation or bleeding time.

**Why Each Wrong Option is Incorrect**
**Option A:** This drug is a classic inhibitor of COX enzymes, which are essential for the production of TXA2. By inhibiting COX, this drug impairs platelet activation and aggregation, leading to prolonged bleeding time.

**Option B:** This drug also affects platelet function by inhibiting the production of TXA2. Additionally, it can cause vasodilation, which further contributes to the prolongation of bleeding time.

**Option C:** This drug can cause prolonged bleeding time by inhibiting the production of vitamin K-dependent clotting factors in the liver.

**Clinical Pearl / High-Yield Fact**
When evaluating a patient with prolonged bleeding time, it's essential to consider their medication history, especially anticoagulants and antiplatelet agents.

**Correct Answer: D. Warfarin**